What This Therapeutics Insider Signals Revenue Momentum
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
See what results to expect from zero based budgeting and how to monitor progress with clear, actionable metrics.
19,375 articlesA high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Jim Cramer tells CNBC’s Mad Money Investing Club to sell Oracle and avoid liquor stocks, outlining a mix of defensive...
Oklo stock surged as investors weighed its plans for advanced reactors against the fast-moving AI data-center boom. T...
Palo Alto Networks’ stock fell after the latest earnings, as traders weighed a murky near-term outlook against the co...
Want to understand how Extra Space Storage (EXR) earns and how to read its earnings calls like a pro? This deep dive ...
Palantir has slipped significantly from its all-time high, prompting questions about a buy-the-dip opportunity. This ...
In Buffett's final chapters as Berkshire's CEO, one move stood out: selling a stock that helped build his fortune. Th...
Major retailers report this week to reveal whether consumer demand is stabilizing and margins are restoring. Here’s w...
February brought a sharp drop for Atlassian as investors digested earnings signals and AI risk. This guide breaks dow...
Rocket Lab’s stock faced a sharp pullback before rebounding in March. This article breaks down what caused the drop, ...
Micron stock has jumped this year but pulled back in early 2026. Analysts say the AI memory demand cycle could push M...
A hedge fund famous for bold bets shows a striking concentration: nearly half of its $14 billion stock portfolio sits...